|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-12-25
|
|
pubmed:abstractText |
Vancomycin susceptibility, the accessory gene global regulator (agr) genotype and function, staphylococcal cassette chromosome (SCC) mec type, and susceptibility to cationic thrombin-induced platelet microbicidal protein 1 (tPMP-1) have been individually predictive of duration of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. This investigation evaluated the interrelationship of these factors with time to clearance of MRSA bacteremia during vancomycin therapy in patients without endocarditis.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-11036055,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-11302791,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-11717293,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-11959587,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-12409375,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-1416849,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-14530781,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-14638503,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-14727222,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-15184410,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-15227615,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-15319865,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-1541535,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-15504869,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-17060545,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-17158941,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-17407040,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-17452488,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-18042628,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-18171250,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-18591266,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-18606839,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-18694905,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-18701261,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-19086913,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-19106348,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-19260820,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-9038312,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-9234789,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-9632628,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20001853-9835510
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Agr protein, Staphylococcus aureus,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/PPBP protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators,
http://linkedlifedata.com/resource/pubmed/chemical/Vancomycin,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Thromboglobulin,
http://linkedlifedata.com/resource/pubmed/chemical/mecA protein, Staphylococcus aureus
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1537-6613
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
201
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
233-40
|
|
pubmed:dateRevised |
2011-9-26
|
|
pubmed:meshHeading |
pubmed-meshheading:20001853-Aged,
pubmed-meshheading:20001853-Aged, 80 and over,
pubmed-meshheading:20001853-Anti-Bacterial Agents,
pubmed-meshheading:20001853-Bacteremia,
pubmed-meshheading:20001853-Bacterial Proteins,
pubmed-meshheading:20001853-Female,
pubmed-meshheading:20001853-Genotype,
pubmed-meshheading:20001853-Humans,
pubmed-meshheading:20001853-Kaplan-Meier Estimate,
pubmed-meshheading:20001853-Male,
pubmed-meshheading:20001853-Methicillin-Resistant Staphylococcus aureus,
pubmed-meshheading:20001853-Microbial Sensitivity Tests,
pubmed-meshheading:20001853-Middle Aged,
pubmed-meshheading:20001853-Trans-Activators,
pubmed-meshheading:20001853-Vancomycin,
pubmed-meshheading:20001853-beta-Thromboglobulin
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes.
|
|
pubmed:affiliation |
Cubist Pharmaceuticals, Lexington, Massachusetts, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
